GILD Stock UPDATES Gilead Sciences (GILD) 105.93 09/18/2014

New Post Public Reply Private Reply Replies (0) Message Board

Sep 18, 2014 at 7:44 PM

Gilead Sciences (GILD) 105.93 $GILD

Most active Nasdaq-traded stocks
AP - 1 hr 39 mins ago
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading:

Final Glance: Biotechnology companies
AP - 1 hr 39 mins ago
NEW YORK (AP) — Shares of some top biotechnology companies were up at the close of trading:

Sanofi & MyoKardia Ink Deal to Develop Cardiomyopathies - Analyst Blog
Zacks Equity Research - Zacks Investment Research - 2 hrs 9 mins ago
Sanofi (SNY) announced that it has entered into an agreement with MyoKardia, Inc. to discover and develop targeted therapeutics for cardiomyopathies.

Bayer/Orion Progress with Prostate Cancer Drug ODM-201 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - 2 hrs 29 mins ago
Bayer (BAYRY) and Orion Corp. announced that they have started enrolling patients for a phase III study on ODM-201.

Alnylam (ALNY) to File Clinical Trial Application for ALN-CC5 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - 2 hrs 34 mins ago
Alnylam Pharmaceuticals (ALNY) intends to file a clinical trial application for ALN-CC5 by year end.

Gilead Down on Weak Simtuzumab Data and Sovaldi News - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Sep 18, 3:16PM CDT
Shares of Gilead (GILD) were down following a couple of setbacks.

Midday Glance: Biotechnology companies
AP - Thu Sep 18, 12:18PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are up at 1 p.m.:

Is It Time to Buy Dividend Stock Bristol-Myers Squibb Co?
George Budwell, The Motley Fool - Motley Fool - Thu Sep 18, 9:57AM CDT
Big Pharma's battle with the patent cliff has led to drastic changes across the healthcare sector. Companies have slashed workforces, changed the focus of their product and clinical portfolios, and even moved abroad to lower their effective tax...

ImmunoCellular Therapeutics (IMUC) Jumps: Stock Up 9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Sep 18, 8:58AM CDT
ImmunoCellular Therapeutics, Ltd. (IMUC) was a big mover last session, as its shares rose nearly 9% on the day.

Halozyme Therapeutics (HALO) Jumps: Stock Up 9.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Sep 18, 8:39AM CDT
Halozyme Therapeutics, Inc. (HALO) was a big mover last session, as its shares rose over 9% on the day.

Repros Therapeutics (RPRX) Crumbles: Stock Falls by 10.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Sep 18, 7:51AM CDT
Repros Therapeutics Inc. (RPRX) saw a big move last session,continuing the recent downtrend for RPRX, as the stock is now down more than 11.5% in the past one-month time frame.

Gilead Sciences, inc. Stock's Incoming Game Changer
Todd Campbell, The Motley Fool - Motley Fool - Thu Sep 18, 7:45AM CDT
Gilead Sciences ' Sovaldi may have revolutionized hepatitis C treatment, but it also served as a lightning rod of controversy over drugmakers' pricing of next-generation medicines. Sovaldi's ability to clear the virus in 90% of patients over 12...

3 Best Stocks for Investing in Biotech
Todd Campbell, The Motley Fool - Motley Fool - Thu Sep 18, 7:35AM CDT
Few baskets are as hit-and-miss as biotech. The group is notoriously fickle and maddeningly volatile -- and for good reason. Whims and whispers tied to the latest clinical trial results can move biotech stocks in fits and starts, making them best...

Market Maker Surveillance Report. EPGL, CMCSA, GILD, YHOO, MSFT, VALE, Bearishly Biased Price Friction For Wednesday, September 17th 2014
M2 - Thu Sep 18, 3:25AM CDT
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Wednesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Wednesday there were 4737 companies with "abnormal" market making, 2409 companies with positive Friction Factors and 2599 companies with negative Friction Factors. Here is a list of the top companies with Abnormal Price Friction (bearish bias) in their stock prices. This means that there was more buying than selling in the stocks and their stock prices dropped. EP GLOBAL COMMUNICATIONS INC (OTC:EPGL), Comcast Corp (NASDAQ:CMCSA), GILEAD SCIENCES, INC. (NASDAQ:GILD), Yahoo! Inc (NASDAQ:YHOO), MICROSOFT CORPORATION (NASDAQ:MSFT), Vale SA (NYSE:VALE). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Jim Cramer's 'Mad Money' Recap: Hooray for the Federal Reserve
at The Street - Wed Sep 17, 7:08PM CDT
Now that the Fed has done the right thing on monetary policy, investors should stop worrying and start thinking about how to make more money, Cramer says.

Merck Posts Positive Data on Osteoporosis Drug Odanacatib - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Sep 17, 6:15PM CDT
Merck & Co. Inc. (MRK) announced encouraging data from a pivotal phase III fracture outcomes study evaluating the use of odanacatib in postmenopausal women suffering from osteoporosis.

Shire's Vyvanse Accepted for FDA Review for Binge Eating - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Sep 17, 6:00PM CDT
Shire plc (SHPG) recently announced that the FDA has accepted its filing with priority review a supplemental New Drug Application (sNDA) for Vyvanse for treating adults with binge eating disorder.

UCB-Amgen Reveals Positive Data on Romosozumab for PMO - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Sep 17, 5:40PM CDT
UCB SA (UCBJF) and Amgen announced positive results from exploratory analyses of a phase II study on romosozumab in postmenopausal women with low bone mineral density.

Abbott Labs (ABT) to Initiate New Trial on Absorb - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Sep 17, 4:05PM CDT
Abbott Labs (ABT) recently announced that it will initiate a trial, ABSORB IV, on bioresorbable vascular scaffold (BVS) Absorb.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Jacobite Steam Train Redefines the Harry Potter Experience

Turn Fantasy into Reality: A Ride Unlike Any Other Ever fantasized about stepping right into the pages of your favorite tale? Well, the Jacobite Steam Train gives Potterheads just that: a literal ride through Harry Potter’s world, but in the heart of Scotland. As HBO's fresh take on the Harry Potter series is about to drop this Christmas, the buzz is lining the tracks...

Pharmacy Credentials Gain Importance in Delaware Law

Credentialing Takes Front Seat in Pharmacy World Well, hold onto your hats because the pharmacy profession is getting a major upgrade, particularly if you're an investor watching healthcare regulation. The American Association of Colleges of Pharmacy (AACP) has thrown its support behind professional credentialing for pharmacists, which is a big deal, trust me. Pharmacy...

Kalfus & Nachman Celebrated for Stellar Workplace Culture

Acknowledging Excellence in the Legal Workplace Now, you wouldn't expect a law firm to top everyone's dream workplace list, but Kalfus & Nachman sure are flipping the script. Named one of the 2026 Best Places to Work: Law Firms, these folks out of Virginia are proving that a solid workplace culture goes hand-in-glove with legal prowess. This accolade's no fluff piece; it...

Bluehost's AI Builder Delivers Swift Web Solutions

Bluehost's Game-Changer for Small Businesses In a world where business agility often trumps size, Bluehost has rolled out a tool that could indeed level the playing field for small enterprises. Enter the Bluehost AI Builder, a platform that promises to take a business concept and whip it into a thriving online presence in mere minutes. No coding, no developer team, no...

Rising Tide: Luxury Cruises Attract Broader Audience

The Lure of the High Seas Who knew luxury cruises would ever shed their elitist skin and become every man's (and woman's) dream? That's what the latest survey from Cruiseline.com and Shipmate is scribbling across the page. Once a playground for the glitzy crowd, luxury cruising now appeals to a broader swath of travelers. They’ve tossed tradition overboard and are...

Navigating Car Wreck Chaos for Legal Protection

Clarity Amid Chaos: Handling a Crash in Abilene Let me tell you, if your day starts with a car wreck, every second post-crash counts more than you think. Attorney Chaile Allen out of Abilene's laying down the law on how to protect yourself—because that wreck scene ain't just about bent fenders and bruised egos. It's about getting your ducks in a row for any potential...

CMC's CFO Shift: Kenji Hashimoto Steps In

CMC's Strategic Financial Transition In the sometimes wild world of business, changes at the top can send ripples through an organization like a hammer strike on a steel pipe. CMC, known for its construction solutions, has announced just such a change with its chief financial officer. Paul Lawrence, the financial hand on the tiller since 2019, is hopping off the boat come...

2027's Top Biopharma Workplaces: Key Insights Unveiled

Life Sciences Workplace Spotlight Finding a workplace that doesn't feel like it's sapping the life out of you is no mean feat these days, but BioSpace has gone ahead and compiled a list that might make the job a bit easier for those scouring the biopharma sector. The 2027 Best Places to Work list just dropped, showering accolades on 50 companies making waves for their...

NHTSA, Ad Council Unveil New Anti-Buzzed Driving PSAs

Taking Aim at a Deadly Habit Everyone's got that gut feeling when a day-long meeting runs over or you're stuck in traffic — impatience morphed with slow burn menace. Now picture a whole campaign gunning for that vibe but in the hands of the young folks, those from 21 to 34. That's what we're talking about here, with the Ad Council and NHTSA serving up some fresh public...

Kavalan Whisky Expands into Ghana with Say Cheers

A Taste of Taiwan in Ghana The whisky world just got a bit smaller with Kavalan’s latest move If you know whisky, you know Kavalan, the Taiwanese gem that's been steadily building its global footprint. And now, they've set their sights on Ghana. Yup, this one's not about rattling sabers but raising glasses! Partnering with Say Cheers Limited, Kavalan enters Ghana,...